Anna studied Biology, with an emphasis on Cell, Molecular and Developmental Biology at the University of Crete, Greece. During her PhD in Queen Mary, University of London she did the knockout of Flavin-containing monoxygenase 5 (Fmo5) gene of the mouse, which eventually led to the identification of Fmo5 as a regulator of metabolic aging. As a Postdoc at the Universities of Ioannina, Greece and the University of Cambridge, UK she investigated the role of cell-surface receptors (Wnt/Notch/FGF4) and adherens junctions in the fate specification of mouse embryonic stem cells (mESs) and mES-derived multipotent cardiac progenitors. Also at the University of Cambridge, UK in John McCafferty’s lab she developed a mES-based phenotypic screening system for selecting antibodies affecting cell-surface receptor signalling, from large antibody phage-display libraries. Anna was previously a Manuscript Editor in a variety of medical and biological BMC Series journals (March 2019 - October 2020). Since November 2020 she is the Editor of BMC Cardiovascular Disorders and BMC Endocrine Disorders. Anna is committed to open access publishing of robust and reproducible science that makes a valid contribution to the scientific knowledge.